logo

Intel, Nvidia, Eli Lilly rise premarket; BP, Novo Nordisk fall

Investing.com -- U.S. stock futures edged higher Tuesday, with traders awaiting the start of a two-day testimony from Fed chief Jerome Powell to Congress.


Here are some of the biggest premarket U.S. stock movers today:


  • Intel (NASDAQ:INTC) stock leapt 2.4% after gaining over 6% in the previous session, while Nvidia (NASDAQ:NVDA) rose 1.5% and Marvell (NASDAQ:MRVL) was up 0.5%, as stocks linked with AI continued to be favored.
  • Amazon (NASDAQ:AMZN) stock rose 0.2% after the online retail giant announced a new $79 Echo Spot alarm clock with a revamped design and improved audio quality.
  • Pfizer (NYSE:PFE) stock rose 0.1% after it announced its chief scientific officer Mikael Dolsten would step down after a more than 15-year career at the drugmaker.
  • Eli Lilly (NYSE:LLY) stock rose 0.4% and Novo Nordisk (CSE:NOVOb) (NYSE:NVO) stock fell 1.8% after the publication of a data analysis showing Eli Lilly's treatment Mounjaro leads to faster and greater weight loss than Novo’s popular obesity drug Wegovy.
  • Lucid Group (NASDAQ:LCID) stock fell 0.6% after the EV manufacturer will have to recall over 5,000 of its 2022-2023 Air luxury sedans due to a software error that could cause a loss of power.
  • BP (LON:BP) (NYSE:BP) ADRs fell 4.1% after the energy giant warned that its second-quarter results will be hit by lower refining margins and it also expects to post an impairment of up to $2 billion.
  • Helen of Troy (NASDAQ:HELE) stock slumped 27% after the consumer products company reported disappointing first-quarter results and slashed its full-year outlook, amid particular weakness in its beauty and wellness business.
Disclaimer: The content of this article solely represents the author's personal opinions and does not reflect the official stance of Tradingkey. It should not be considered as investment advice. The article is intended for reference purposes only, and readers should not base any investment decisions solely on its content. Tradingkey bears no responsibility for any trading outcomes resulting from reliance on this article. Furthermore, Tradingkey cannot guarantee the accuracy of the article's content. Before making any investment decisions, it is advisable to consult an independent financial advisor to fully understand the associated risks.